MUGENBIO

MUGENBIO is a biotech startup based in Kanton Zurich, Switzerland. Our mission is to break technological barriers in the way of medical diagnostics.

[MUGENBIO @mugenbio]

We need more research and development of the next generation of prostate cancer diagnostics to limit unnecessary biopsies and overtreatment of nonagresive prostate tumors. The work from Dr Linda Kachuri at Stanford, exemplify the research we need.

https://t.co/XTrsb2cCir

[MUGENBIO @mugenbio]

Cancer metabolism is slower than we thought. Interestingly, the metbolic rate is changing upon transition from primary to metastatic tumor. Very important observation which will help in formulating better anti-cancer treatments and drug designs.

https://t.co/PcFD3D7def

[MUGENBIO @mugenbio]

@elonmusk predicted that the humanity will most likely face existential crisis during our lifetime. The current meta study confirms that the global male fertility is in sharp decline. We need to develop better methodology for measuring male fertility now!

https://t.co/41mEGL2ScZ

[MUGENBIO @mugenbio]

We should rise the awareness of bladder cancer symptoms and we need to innovate medical diagnostic methods of detection of this disease.

#Science #Technology #Medicine #Personalised #Diagnostic #Early #Diagnosis #Cancer #Bladder

https://t.co/gtQd92OslC

[MUGENBIO @mugenbio]

Excellent article on current situation of prostate cancer diagnostics. It is clear that we need to improve testing for this cancer ASAP! An early detection of cancer translates in more patients saved.

https://t.co/vrr6N682oM

[MUGENBIO @mugenbio]

As @elonmusk has mentioned a number of times, the biggest threat to our civilisation is #underpopulation, and the male #infertility is a large contributor to this global problem. It is highest time to start discussing and tackling this issue.

https://t.co/ABoVxrXxvR